TABLE 3.
Non-drinker | Low-risk, no binge | Low-risk, binge | High-risk | |
---|---|---|---|---|
Crude | ||||
Overall | 1. | 1.03 (0.95, 1.11) | 1.09 (1.00, 1.19) | 1.26 (1.09, 1.44) |
Men | 1. | 1.02 (0.94, 1.12) | 1.09 (0.99, 1.20) | 1.24 (1.05, 1.47) |
Women | 1. | 1.08 (0.93, 1.26) | 1.16 (0.98, 1.38) | 1.30 (1.01, 1.69) |
Adjusteda | ||||
Overall | 1. | 1.09 (1.01, 1.18) | 1.17 (1.07, 1.28) | 1.24 (1.04, 1.49) |
Men | 1. | 1.08 (0.99, 1.18) | 1.17 (1.06, 1.29) | 1.22 (1.00, 1.50) |
Women | 1. | 1.11 (0.94, 1.32) | 1.19 (0.98, 1.44) | 1.33 (0.95, 1.87) |
Abbreviations: CNICS, Centers for AIDS Research Network of Integrated Clinical Systems; eGFR, estimated glomerular filtration rate; FIB-4, Fibrosis-4 Index for Liver Fibrosis; IDU, injection drug use; MSM, men who have sex with men; VACS, Veterans Aging Cohort Study
Adjustment for sex; race/ethnicity; MSM, IDU; calendar year; CNICS clinic; modified VACS index (a function of age, CD4 cell count, hemoglobin, FIB-4, eGFR, and hepatitis C viral infection); recent and prior cocaine and opioid use; panic symptoms; depressive symptoms; and current smoking